Monday, October 8, 2012

Ancillary Studies in Clinical Trials (R01)

Ancillary Studies in Clinical Trials (R01)

Department of Health and Human Services


The synopsis for this grant opportunity is detailed below, following this paragraph. This synopsis contains all of the updates to this document that have been posted as of 09/28/2012 . If updates have been made to the opportunity synopsis, update information is provided below the synopsis.
If you would like to receive notifications of changes to the grant opportunity click send me change notification emails . The only thing you need to provide for this service is your email address. No other information is requested.

Any inconsistency between the original printed document and the disk or electronic document shall be resolved by giving precedence to the printed document.
Document Type:Grants Notice
Funding Opportunity Number:RFA-HL-14-004
Opportunity Category:Discretionary
Posted Date:Sep 28, 2012
Creation Date:Sep 28, 2012
Original Closing Date for Applications:Jan 24, 2014   
Current Closing Date for Applications:Jan 24, 2014   
Archive Date:Feb 24, 2014
Funding Instrument Type:Grant 
Category of Funding Activity:Health 
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:$250,000
Award Floor:
CFDA Number(s):93.233  --  National Center on Sleep Disorders Research
93.837  --  Cardiovascular Diseases Research
93.838  --  Lung Diseases Research
93.839  --  Blood Diseases and Resources Research
Cost Sharing or Matching Requirement:No

Eligible Applicants

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Information on Eligibility:

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 

Agency Name

National Institutes of Health


This Funding Opportunity Announcement (FOA) invites research grant applications to conduct time-sensitive ancillary studies related to heart, lung, and blood diseases and sleep disorders in conjunction with ongoing clinical trials and other large clinical studies supported by NIH or non-NIH entities. The program establishes an accelerated review/award process to support the crucial time frame in which these ancillary studies must be performed. Time-sensitive ancillary studies include those that require active longitudinal data collection and thus need to begin recruiting subjects as close as possible to the start of the parent study. The ancillary study can address any research questions related to the mission of NHLBI for which the parent study can provide participants, infrastructure, and data. The parent studies most often will be a clinical trial, but also can be an observational study or registry that can provide a sufficient cohort of well-characterized patients. Each ancillary study application must demonstrate the time-sensitive nature of the application and must explicitly address why an expedited review is essential to its feasibility. 

Link to Additional Information

If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Synopsis Modification History

No comments:

Post a Comment